Evidence map›Paper›PMID 39753633›Full record

ArticleScientific reports2025

Experimental and theoretical investigation of cyclohexanone derivative (CHD) as a corrosion inhibitor for mild steel in 1 M HCl.

B M Praveen, A S Jeevan Chakravarthy, B M Prasanna, Shabanbanu, Bharath K Devendra, M K Pavithra, Fasiulla

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

B M PraveenDepartment of Chemistry, Institute of Engineering and Technology, Srinivas University, Mukka, Mangaluru, Karnataka, 574146, India.
A S Jeevan ChakravarthyDepartment of Chemistry, BMSIT&M (Affiliated to Visvesvaraya Technological University, Belagavi), Avalahalli, Yelahanka, Bengaluru, Karnataka, 560064, India.
B M PrasannaDepartment of Chemistry, Bapuji Institute of Engineering and Technology (Affiliated to Visvesvaraya Technological University, Belagavi), Davanagere, Karnataka, 577004, India.
ShabanbanuDepartment of Chemistry, Government Engineering College (Affiliated to Visvesvaraya Technological University, Belagavi), Haveri, 581110, Karnataka, India.
Bharath K DevendraDepartment of Chemistry, M. S. Ramaiah College of Arts, Science and Commerce(Autonomous), Bengaluru, Karnataka, 560054, India.
M K PavithraDepartment of Chemistry, Sahyadri Science College, Shivamogga, Karnataka, 574146, India.
FasiullaDepartment of Chemistry, Manipal Institute of Technology, Manipal Academy of Higher Education, Manipal, Karnataka State, 576104, India. fasi.khan@manipal.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Newly synthesized 1-bromo-2-(4-bromophenylsulfonate)-4,4-dimethyl-1-cyclohexenyl-6-one (CHD) as a potential anticorrosive agent in an acidic medium at an elevated temperature range of 305-335 K. This synthesized compound confirmed by spectral characterizations and it acts as a coating on mild steel surfaces in 1 M Hydrochloric acid (HCl) solution through electrochemical reactions. The synthesis of the compound has been discussed, and the Infrared (IR) and Nucleic Magnetic Resonance (NMR) spectral analysis confirmed the derivative. Afterward, the synthesized compound was subjected to various electrochemical investigations. This suggested that in 1 M Hydrochloric acid (HCl), the compound efficiently prevents mild steel corrosion. Potentiodynamic polarisation studies demonstrate that the E

Indexed as

Corrosion inhibitorsElectrochemicalSurfacesThermodynamics

Identifiers

PMID39753633
PMCPMC11698742

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.